ENDOSSEOUS DENTAL IMPLANT PLACEMENT IN FOUR SUBGROUPS RECOMMENDED BY FDA DENTAL PRODUCTS PANEL; IMPLANT ABUTMENTS SHOULD BE CLASSIFIED SEPARATELY
This article was originally published in The Gray Sheet
Executive Summary
Endosseous dental implants should be placed in four separate subgroups for consideration of reclassification, FDA's Dental Products Panel concluded at a Nov. 4 meeting in Bethesda, Maryland. The four subgroups -- root form implants, blade implants, implants with special retention features and temporary implants -- represent device types for which different degrees of regulatory control may be required to assure safety and effectiveness, the panel stated.